top
Search terms
Results 1 - 7 of 7 - ordered by :
Ehjcvp

[...]of progress made in HFREF therapy, cumulative mortality benefit amounts to almost a three-fold decrease in death rate whether in severe or in mild-to-moderate HFREF. In chronic HEFREF, it is ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Faiez Zannad

Date : 01/01/2015 Item size : 180641 bytes
Ehjcvp

Introduction The presence of atrial fibrillation (AF) increases the risk of stroke and thrombo-embolism, and given how common AF is, this represents a considerable healthcare and public health ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Gregory Y.H. Lip

Date : 01/04/2015 Item size : 213366 bytes
Ehjcvp

An index of new research activity in Cardiovascular Pharmacotherapy can be obtained by listing the number of new updates in the 8th edition of Drugs for the Heart2 that covers all the main areas of ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Lionel H. Opie

Date : 01/04/2015 Item size : 144582 bytes
Ehjcvp

Abstract Aortic valve stenosis (AVS) is associated with significant morbidity and mortality, especially in the presence of symptoms and echocardiographic signs of left ventricular remodelling (i.e. ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Charlotte Andersson, Jawdat Abdulla

Date : 11/09/2016
Ehjcvp

Heart failureIron deficiencyIntroduction Heart failure (HF) is a common condition and one that is projected to increase significantly in the coming decades due to the ageing population and increased ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Sarah Fitzsimons, Robert Neil Doughty

Date : 01/01/2015
Ehjcvp

Abstract The 2016 European Society of Cardiology Heart Failure society as well as the 2016 American Heart Association/American College of Cardiology/Heart Failure Society of America heart failure ...

European Heart Journal - Cardiovascular Pharmacotherapy, Review, Bertram Pitt, João Pedro Ferreira, Faiez Zannad

Date : 01/08/2016
Ehjcvp

When I graduated from New York University's School of Medicine in 1952, drugs available for the management of cardiovascular diseases were few and with the exception of nitroglycerine, which was ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Eugene Braunwald

Date : 01/01/2015